• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Neurodegenerative Disease Market Research Reports
Category
Pharmaceutical (6699)
Biologics (255)
Biomarker (97)
Biomaterials (72)
Biotechnology Equipment (455)
Cancer (1033)
Diabetes (179)
Drug Delivery System (132)
Drug Discovery (2152)
Drug Regulation (116)
Gene Therapeutics & RNAi (90)
Generic Drugs (86)
Genome-based Drug Discovery (142)
Infectious Disease (328)
Molecular Targeted Therapeutics (201)
Neurodegenerative Disease (222)
OTC Drug (101)
Personalized Medicine (56)
Pharmaceutical Companies (675)
Prescription Drugs (471)
Regenerative Medicine (130)
Vaccines (220)

Neurodegenerative Disease Market Research Reports

We offer reports covering rare and common neurodegenerative diseases such as MS, dementia, Alzheimer’s, and epilepsy. Central nervous system drugs are covered individually in the research, which contains information regarding drug pipelines and R&D challenges, as well as assessments of market potential.

Filter
Title Search
1 - 25 of 222 Products Sort by Display
Biomarkers in Alzheimer's Disease
Product code:308694
Published by Insight Pharma Reports
Published July 23, 2014 Price USD 699
Content info 95 Pages
Sample available
Global Parkinson's Disease Market 2014-2018
Product code:278974
Published by Infiniti Research Limited (Technavio)
Published July 23, 2014 Price USD 2500
Content info 97 Pages
Sample available
The Global Parkinson's Disease market is expected to post a CAGR of 1.67 percent during the forecast period. One of the main drivers of the market is the steadily growing aging population worldwide. Aging is one of the main causes of CNS disorders, includ...
Drug Delivery in Central Nervous System Diseases - technologies, markets and companies
Product code:70934
Published by Jain Pharmabiotech
Published July 1, 2014 Price USD 3000
Content info  
The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders....
*
Product code:70927
Published by Jain Pharmabiotech
Published July 1, 2014 Price USD 4000
Content info  
Alzheimer' s disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechan...
*
Product code:70919
Published by Jain Pharmabiotech
Published July 1, 2014 Price USD 5000
Content info  
This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many of the underlying mechanisms of damage to neural tissues...
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014
Product code:307774
Published by GlobalData
Published June 30, 2014 Price USD 2500
Content info 72 Pages
Sample available
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
Product code:133572
Published by BCC Research
Published June 27, 2014 Price USD 6650
Content info 129 Pages
Sample available
The total worldwide market for MS disease-modifying therapies is expected to grow at an 8.1% compound annual growth rate (CAGR) from 2010 through 2015....
OpportunityAnalyzer: Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2018
Product code:306633
Published by GlobalData
Published June 20, 2014 Price USD 5995
Content info 134 Pages
Sample available
Global Alzheimer's Drugs Market 2014-2018
Product code:273286
Published by Infiniti Research Limited (Technavio)
Published June 20, 2014 Price USD 3000
Content info 108 Pages
Sample available
Inhaled CNS Therapeutics
Product code:304994
Published by Greystone Research Associates
Published June 4, 2014 Price USD 2850
Content info  
Sample available
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014
Product code:302387
Published by GlobalData
Published May 15, 2014 Price USD 2500
Content info 99 Pages
Sample available
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014
Product code:302385
Published by GlobalData
Published May 15, 2014 Price USD 2500
Content info 127 Pages
Sample available
EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2023
Product code:258690
Published by GlobalData
Published May 15, 2014 Price USD 3995
Content info 61 Pages
Sample available
Global Diabetic Neuropathy Market 2014-2018
Product code:302347
Published by Infiniti Research Limited (Technavio)
Published May 9, 2014 Price USD 2500
Content info 55 Pages
Sample available
EpiCast Report: Amyotrophic Lateral Sclerosis - Epidemiology Forecast to 2023
Product code:301139
Published by GlobalData
Published May 1, 2014 Price USD 3995
Content info 38 Pages
Sample available
PharmaPoint: Neuropathic Pain - Current and Future Players
Product code:302384
Published by GlobalData
Published April 30, 2014 Price USD 2995
Content info 51 Pages
Sample available
CNV-1014802 (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302382
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 86 Pages
Sample available
CNV-2197944 (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302381
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 86 Pages
Sample available
Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302380
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 85 Pages
Sample available
Topical Clonidine (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302379
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 88 Pages
Sample available
Eladur (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302378
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 86 Pages
Sample available
DS5565 (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302377
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 87 Pages
Sample available
Eslicarbazepine acetate (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302376
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 87 Pages
Sample available
Qutenza (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302375
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 69 Pages
Sample available
Lidoderm/Versatis (Neuropathic Pain) - Forecast and Market Analysis to 2022
Product code:302374
Published by GlobalData
Published April 30, 2014 Price USD 3495
Content info 68 Pages
Sample available